Microneedling Market

The increase in demand for minimally invasive procedures to boost the market growth

Demand for minimally and non-invasive skin rejuvenation and body contouring procedures using novel radiofrequency systems is growing at a rapid pace. These minimally and non-invasive technologies have become the fastest-growing areas of aesthetic medicine. Microneedling is a minimally invasive, non-ablative technique commonly used for body contouring, skin tightening, and cellulite reduction.

Moreover, electromagnetic technology is based on the use of an oscillating electrical current that generates and delivers thermal energy to the deep dermis and subcutaneous fat that stimulates the production of collagen, elastin, and hyaluronic acid, resulting in skin tightening and lifting, while causing minimal damage to superficial structures of the skin. For instance, in February 2020, US Food and Drug Administration has approved Lutronic’s (US) genius microneedling platform or radiofrequency microneedling. Lutronic genius microneedling platform is a minimally invasive cosmetic treatment used to reduce the appearance of wrinkles, scarring, and sagging skin.

As a result, the microneedling market is expected to be driven by an increase in demand for minimally invasive procedures.

The biggest benefit of medical travel is the cost savings because facilities in underdeveloped nations can charge less because of the country's economic situation.

The Global Microneedling Market Industry experiences a surge in demand for aesthetic procedures, driven by an increasing consumer focus on skin health and appearance. As individuals become more aware of the benefits of non-invasive treatments, microneedling emerges as a preferred option due to its effectiveness in addressing various skin concerns. In 2024, the market is valued at approximately 0.57 USD Billion, reflecting a growing acceptance of microneedling among consumers. This trend is anticipated to continue, with projections indicating that the market could reach 1.65 USD Billion by 2035, suggesting a robust growth trajectory fueled by evolving beauty standards.

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North American microneedling market accounted for the largest market share in 2022. This is due to the increasing incidence of alopecia and different dermatological diseases and the presence of advanced healthcare facilities and skilled professionals in the region, and the rising strategic partnership and increasing investment by major players in the region. 

Further, increasing technological advancement and rising awareness about microneedling procedures in the region are expected to further drive the growth of the regional segment in the market of microneedling. Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: MICRONEEDLING MARKET BY REGION 2023 & 2030

Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

Europe microneedling market accounts for the second-largest market share due to the growing support by government bodies for the use of minimally invasive procedures, the increasing number of product approvals and the availability of products across the region, and the growing popularity of minimally invasive technology in the region. furthermore, the Germany market of microneedling was attributed to holding the largest market share, and the UK market of microneedling is expected to fastest-growing market in the European region.

The Asia-Pacific microneedling market is expected to grow at a significant share from 2023 to 2030. This is due to the increase in the demand for antiaging treatment, the rise in the standard of living, and the growing R&D activities in surgical procedures in the Asia-Pacific region. Moreover, Japan market of microneedling is expected to hold the largest market share, and India market of microneedling is expected fastest-growing market in the Asia-Pacific region.

Furthermore, the growing consumer disposable income levels in emerging countries and growing technological innovation are likely to have considerable market growth for the microneedling.

The Rest of the World is segmented into the Middle East, Africa, and Latin America. The market for microneedling in the above-mentioned regions is likely to witness growth due to the rising prevalence of minimally-invasive procedures and the rising aesthetic consciousness among consumers in these regions. Moreover, increasing healthcare expenditure and the growing awareness of microneedling procedures are expected to propel the microneedling market growth in the region.

The Microneedling Market is characterized by the presence of many global, regional, and local vendors catering to the demand created by research scientists and pharmaceutical and biotechnology companies operating in the industry. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such as Crown Aesthetics (US), Lumenis Be Ltd (Israel), Aesthetics Biomedical (US), and INMODE (US) dominate the market of Microneedling due to product differentiation, financial stability, strategic developments, and diversified regional presence. 

The players are focused on investing in research and development. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base. One of the primary business strategies adopted by manufacturers in the global microneedling industry to benefit clients and expand the microneedling market sector is to manufacture locally to reduce operating costs.

Crown Aesthetics (US) is a manufacturer of premier medical aesthetics equipment. It offers products such as SkinPen, the first FDA-cleared microneedling device, MicroPen EVO, Platelet-rich Plasma (PRP) systems ProGen PRP Advantage and Eclipse PRP, VOTESSE, a hair health system; and the post-micro needling protocol Skinfuse. Crown has excelled in dermatology and aesthetics due to its unwavering pursuit of therapeutic excellence and improved patient results. It has a strong presence in the US, and it distributes products in over 41 countries.

Furthermore, the company operates in North America, Europe, Asia, Oceania, Africa, and the Middle East. For instance, in February 2023, Crown Aesthetics (US) launched the SkinPen Premium Biocellulose Masque microneedling device for post-treatment skin soothing. This new addition to the SkinPen Precision Treatment Kits marks the first premium upgrade to the Treatment Kit options from Crown Aesthetics.

Also, Lumenis Be Ltd (Israel) is a manufacturer and distributor of minimally invasive clinical devices, medical and aesthetic lasers, and light-based systems. The company offers holmium lasers, CO2 lasers, reusable fibers, multi-wavelength lasers, laser photocoagulators, and other aesthetic devices. In addition, the company offers its solutions to a variety of medical environments, including aesthetic, and ophthalmic procedures. It has an operational presence in the Americas, Europe, the Middle East, and Asia-Pacific. Furthermore, it has operations in the US, China, Japan, India, Germany, and Australia.